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Abstract
Susceptibility to osteoporotic fracture is influenced by genetic factors that can be dissected by whole-genome linkage
analysis in experimental animal crosses. The aim of this study was to characterize quantitative trait loci (QTLs) for
biomechanical and two-dimensional dual-energy X-ray absorptiometry (DXA) phenotypes in reciprocal F2 crosses between
diabetic GK and normo-glycemic F344 rat strains and to identify possible co-localization with previously reported QTLs for
bone size and structure. The biomechanical measurements of rat tibia included ultimate force, stiffness and work to failure
while DXA was used to characterize tibial area, bone mineral content (BMC) and areal bone mineral density (aBMD). F2
progeny (108 males, 98 females) were genotyped with 192 genome-wide markers followed by sex- and reciprocal cross-
separated whole-genome QTL analyses. Significant QTLs were identified on chromosome 8 (tibial area; logarithm of odds
(LOD)=4.7 and BMC; LOD=4.1) in males and on chromosome 1 (stiffness; LOD=5.5) in females. No QTLs showed significant
sex-specific interactions. In contrast, significant cross-specific interactions were identified on chromosome 2 (aBMD;
LOD=4.7) and chromosome 6 (BMC; LOD=4.8) for males carrying F344mtDNA, and on chromosome 15 (ultimate force;
LOD=3.9) for males carrying GKmtDNA, confirming the effect of reciprocal cross on osteoporosis-related phenotypes. By
combining identified QTLs for biomechanical-, size- and qualitative phenotypes (pQCT and 3D CT) from the same
population, overlapping regions were detected on chromosomes 1, 3, 4, 6, 8 and 10. These are strong candidate regions in
the search for genetic risk factors for osteoporosis.
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Introduction
Osteoporosis is a common multifactorial disorder characterized
by reduced bone mineral density (BMD) and compromised bone
quality, with micro-architectural deterioration leading to an
increased susceptibility to fracture [1]. The ability of bone to
resist fracture is determined by several highly heritable phenotypes
including BMD, bone size, bone structure and strength [2,3,4].
Identification of genes and pathways regulating these phenotypes
and thereby underlying bone strength could provide valuable
insight regarding susceptibility to osteoporosis and fracture risk.
Translational genetics starting with experimental models is a
valuable tool to dissect complex genetic traits. By using inbred
strains and crosses between strains, genetic heterogeneity is
dramatically reduced and experimental tests, such as destructive
testing of bone, can be performed. One example of successful
translational genetics is the identification of the arachidonate
lipoxygenase 15 (Alox15) gene encoding an enzyme that modifies
polyunsaturated fatty acids, as a candidate for osteoporosis. Mice
deficient in Alox15 were found to have increased bone mass [5]
and subsequent association analyses in humans have shown
association with BMD for SNPs in the human orthologues
ALOX12 and ALOX15 [6,7].
Most experimental genetic studies on bone have been
performed in the mouse [8,9,10,11,12], but observed variations
in BMD, bone structure, and fragility between different inbred rat
strains [13], together with progress in mapping the rat genome has
established the rat as a useful genetic model for skeletal fragility
[14,15,16]. Rat models offer several advantages in studying
biomechanical phenotypes reflecting the ability of bone to resist
fracture, since the larger bone size of rats compared to mice allows
greater precision of both structural and biomechanical measure-
ments. The biomechanical three-point bending test (3PB) used in
this study provides clinically relevant phenotypes comparable to
fracture in humans [17]. Fracture susceptibility is affected by a
number of conditions including diabetes, where hyperinsulinemia
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loss and increased risk of fracture [18,19,20,21,22]. Diabetes is,
however, less extensively studied with regard to fracture compared
to many other conditions. The inclusion of a rat strain with
diabetes-associated phenotypes in linkage analysis of bone
phenotypes thus offers the possibility to identify shared mecha-
nisms e.g. by identifying overlapping quantitative trait loci (QTLs)
for these traits.
In our previous studies using reciprocal F2 crosses from inbred
diabetic GK and non-diabetic F344 rats, we reported results from
a genome-wide screen for size, trabecular and cortical bone
structure of tibia [23,24]. We identified several significant QTLs
for both bone size and structure and additionally found evidence
of sex- and reciprocal cross-specific interactions with bone traits.
The reciprocal crosses differ with regard to grand-maternal origin,
either GK or F344. This has epigenetic effects on the F2 offspring,
but also results in the inheritance of different mitochondria.
Mitochondria have small, circular genomes encoding 13 proteins
taking part in the electron transport chain. The mitochondrial
encoded proteins need to interact with proteins encoded by genes
in the cell nucleus to function correctly. Polymorphisms in nuclear
or mitochondrial DNA affecting such interactions could give rise
to an observed reciprocal effect i.e. differing phenotype, depending
on the combination of nuclear and mitochondrial alleles in the F2
population. Of note, the GK and F344 rat strains used differ in
more than 100 positions in their mtDNA [25,26]. The aims of this
study were to identify QTLs linked to two-dimensional dual-
energy X-ray absorptiometry (DXA) and bone biomechanical
phenotypes in reciprocal rat F2 crosses and to combine these with
previously reported QTLs for bone size and structure. This study
thus addresses all the primary skeletal determinants of fracture risk
including areal BMD (aBMD), bone size, structure and strength
and further delineates the involvement of sex- and reciprocal cross
on the genetic regulation of bone strength related phenotypes.
Materials and Methods
Animals
Rat strains GK/KyoSwe (GK) and F344/DuCrlSwe (F344)
were maintained through brother-sister breeding. Briefly, two
separate F2 intercrosses were generated: one originating from
grand-maternal GK and grand-paternal F344 (cross 1, (GK
female6F344 male) F1), and the other from grand-maternal F344
and grand-paternal GK (cross 2, (F344 female6GK male) F1).
The two groups of reciprocal F1 progeny were mated separately to
yield two reciprocal F2 populations. The rats were maintained
under controlled conditions as reported previously [23]. F2
progeny were sacrificed at a mean age of 215 days and body
weight and length from nose tip to tail-base were recorded. The
left tibia was dissected free of fat and muscle and stored in 70%
ethanol at 220uC prior to biomechanical testing and analysis of
skeletal phenotypes. Genomic DNA was purified from rat liver as
previously described [23]. All experiments were performed with
approval from the local Animal Ethics Committee; Stockholm’s
norra djurfo ¨rso ¨ksetiska na ¨mnd (N189/97), Malmo ¨/Lunds djur-
fo ¨rso ¨ksetiska na ¨mnd (M215-01 and M143-04).
Bone strength-related phenotypes
Biomechanical testing (3PB test): Prior to testing, tibia were
thawed and equilibrated at room temperature (,2 hours). Tibia
were positioned on the lower supports of a three-point bending
fixture (a span of ,16 mm) and held in a stable position by a 2N
preload. Using an Instron 4465 materials testing machine (Instron
Inc., Canton, MA, USA) with a 1KN load cell, the bones were
loaded at their midpoint at a deformation rate of 1 mm/min until
fracture. Load-displacement data representing structural or
extrinsic properties of the bone were calculated from load-
displacement curves and collected using LABView data acquisition
software [27]. Parameters included: ultimate force (N; height of
curve) reflecting the maximum load the bone can absorb before
failing (i.e. bone strength), stiffness (N/mm; initial slope of the load
displacement curve), and work to failure (mJ; area under curve)
reflecting the total energy the bone can absorb before fracture.
Prior to mechanical testing, whole tibiae were scanned by DXA
using the PIXImus
TM densitometer (GE Lunar, Madison, WI).
Bones were precisely positioned at the center of the X-ray cone
beam and scanned in air on the Plexiglas platform provided. A
grid on the Plexiglas platform allowed the position of each tibia to
remain consistent between samples. aBMD was automatically
calculated from the bone mineral content (BMC) and the user-
defined measured region of bone area [28]. The instrument was
calibrated daily using the manufacturer’s phantom. Additionally,
we refer to previously reported phenotypes obtained from three-
dimensional computed tomography (3D CT) and peripheral
quantitative CT (pQCT) [23,24].
Statistical analysis
All phenotypes were normally distributed or log-transformed to
obtain a normal distribution. To compare the bone phenotypes
between males and females and between the reciprocal crosses,
one-way ANOVA was used. The level of significance was set at
p,0.05. Unless stated, p-values are nominal. Phenotypes were
adjusted for reciprocal cross, age, litter size, and body-weight using
regression analyses. Residuals were checked for normality and
used in the QTL analysis. To account for gender attributed bone
quality differences, the residuals were computed separately for
each sex. Correlations between all measured bone phenotypes in
the F2 progeny were evaluated using Pearson’s correlation
coefficients.
Genotyping and linkage analysis of quantitative traits
A total of 192 genome-wide microsatellite markers at a spacing
of 10 cM, were genotyped in the F2 progeny (108 males, 98
females) and a genetic map was generated as described previously
[23]. Linkage analysis was performed for each sex separately. In
order to identify possible interaction differences between loci in the
nuclear genome and mitochondrial DNA, the sex separated F2
progeny were also separated on the basis of reciprocal cross. QTLs
on autosomes were identified employing MAP MANAGER/QTX
v. b20 [29]. R/qtl was used to include the X chromosome in the
linkage analysis and to confirm all reported autosomal QTLs [30].
Mapping QTLs on the X chromosome was conducted for each sex
separately without further separation by cross. Permutation tests
were performed to establish genome-wide significance levels by
randomization of the phenotypic data in relation to genotypic data
[31]. Significant (i.e. genome-wide false-positive rate of ,5%) and
suggestive (i.e. genome-wide false-positive rate of ,63%) linkage
was employed to establish genome-wide thresholds [32,33]. The
likelihood ratio (LR) for suggestive linkage was 10.7 (logarithm of
odds (LOD)=2.3), and for significant linkage the LR range was
17.4–17.7 (LOD=3.8). The approximate size of the QTL was
defined as the region covered by a 1-LOD reduction for any of the
bone traits.
Evaluation of sex- and reciprocal cross specific QTLs
Evaluation of sex- and reciprocal cross specific QTLs were
performed for QTLs that reached significant linkage (LOD$3.8),
following the method described previously [23]. To identify sex-
Co-Localization of Osteoporosis-Related QTLs
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females across the genome were assessed (DLODsex score). We
applied a permutation method to evaluate sex-specific QTLs,
where thresholds were established using two randomly selected
equal sized subsets of males and females [34]. The randomization
was conducted within each cross. Subsequently, the bone
phenotypes in the two subsets were permutated to calculate
DLODsex scores across the genome. Genetic markers on the X
chromosome were not included in the permutation tests. The
average DLODsex score for genome-wide significant sex-specificity
at suggestive (a=0.63) and significant (a=0.05) level were 2.3 and
3.7, respectively.
Within each sex, subsequent reciprocal cross-separated linkage
analyses were conducted to identify cross-specific QTLs. The
LOD score differences between cross 1 and cross 2 (DLODcross
score) across the genome were evaluated. Thresholds of the cross
specific QTLs were computed by permutation using two randomly
selected equal sized cross 1 and cross 2 subsets. The average
DLODcross score for genome-wide significant cross-specificity at
suggestive (a=0.63) and significant (a=0.05) level were 2.4 and
3.9, respectively.
To confirm the sex- and cross-specific QTLs identified with the
DLOD method, likelihood ratio tests were performed comparing a
full model containing a QTL6sex interaction term/cross interac-
tion term and a reduced model without the interaction term. Both
models used male and female data for sex interaction and data
from the two crosses in each sex for cross interaction.
Residuals of each phenotype were examined for normality using
normal probability plots. The level of significance for a specific
QTL interaction with sex or cross was set at p,0.05.
A statistical power calculation for sample size, using the method
of Lynch and Walsh [35] was performed as described previously
[23]. Using a LOD score of 2.4 to control false positive detection
of linkage, a sample size of 52 is necessary to achieve 80%
statistical power for detecting a QTL with R2 value (i.e. fraction of
phenotypic variance explained) of 0.25.
Results
Influence of sex and reciprocal cross on biomechanics
and DXA
Strong sexual dimorphism was observed for all biomechanical
and DXA traits in the F2 progeny with significantly higher mean
values in males. In contrast, no differences were observed between
phenotypic mean values in the two reciprocal F2 crosses (Table 1).
QTLs linked to biomechanics
Results from the sex- and reciprocal cross separated QTL
analyses for biomechanical phenotypes of tibia are summarized in
Table 2. No significant linkage to biomechanical properties was
identified in males when both reciprocal crosses were combined.
When separating males by reciprocal cross, a QTL on
chromosome 15 linked to ultimate force reached genome-wide
significance in cross 1 with GK grand-maternal origin. This QTL
met the criteria for genome-wide cross-specificity at the suggestive
level (DLODcross$2.4), and the likelihood ratio test confirmed a
cross-specific interaction for this locus (LR=10.4, p=0.005)
(Fig. 1B). An overlapping QTL in females from cross 2 was
suggestively linked to work to failure (Table 2).
The maximum LOD-score for biomechanical phenotypes in
females was 5.5 on chromosome 1 (18–43 cM) with significant
linkage to stiffness. This locus also showed linkage to ultimate force
at the suggestive level. The chromosome 1 QTL linked to stiffness
reached genome-wide significance for female-specific interaction
with DLODsex evaluation (DLODsex$3.7, results not shown) but
did not reach significance in the likelihood ratio test. Suggestive
QTLs for biomechanical phenotypes are reported in table S1.
QTLs linked to DXA phenotypes
Results from the sex- and reciprocal cross separated QTL analysis
for DXA traits are summarized in Table 2. In all males, significant
l i n k a g et oB M Ca n dt oa r e aw a si d e n t i f i e do nc h r o m o s o m e8( 3 5 –
59 cM). The chromosome 8 BMC QTL indicated male-specific
Table 1. Biomechanical and DXA data from tibia of female and male F2 progeny generated from GK and F344 in two reciprocal
crosses.
Sex Effects Reciprocal Cross Effects
Irrespective of cross Females Males
Females
(n=98)
Males
(n=108)
% Difference
(p)
Cross 1
(n=48)
Cross 2
(n=50)
% Difference
(p)
Cross 1
(n=66)
Cross 2
(n=42)
% Difference
(p)
General Characteristics
Body weight (g) 248627 426644 242 (,10
24)2 4 7 625 248628 20.4 (NS) 423644 423645 20.05 (NS)
Body length (cm) 21.360.7 24.960.8 214 (NS) 21.360.7 21.260.8 0.5 (NS) 24.960.8 24.960.7 ,0 (NS)
Tibia length (mm) 38.961.3 43.861.3 211 (,10
24) 39.161.2 38.761.3 1.0 (NS) 43.961.3 43.661.2 0.7 (NS)
3- Point Bending Test
Ultimate force (N) 73.4610.0 118615.3 238(,10
24) 73.469.4 73.3610.6 0.1 (NS) 118615.3 118615.5 ,0 (NS)
Work to failure (mJ) 42.8612.0 73.6627.3 242(,10
24) 44.3613.6 41.4610.3 7.0 (NS) 72.6626.7 75.1628.4 23.3 (NS)
Stiffness (N/mm) 205635.6 340665.8 240(,10
24)2 0 7 635.4 204636.0 1.5 (NS) 334656.6 348678.3 24.0 (NS)
DXA
aBMD (g/cm
2) 0.1660.01 0.1860.01 211 (,10
24) 0.1660.01 0.1660.01 ,0 (NS) 0.1860.008 0.1860.009 ,0 (NS)
BMC (g) 0.3160.04 0.4460.05 230(,10
24) 0.3160.03 0.3060.04 3.3 (NS) 0.4460.05 0.4460.05 ,0 (NS)
Projected area (cm
2) 1.9260.14 2.4660.17 222(,10
24) 1.9460.13 1.9060.15 2.1 (NS) 2.4660.18 2.4760.16 20.4 (NS)
Phenotypes are uncorrected and presented as mean 6 sd. Cross 1 originate from grand-maternal GK- and cross 2 from grand-maternal F344 rats.
Percentage difference (female compared to male or cross 1 compared to cross 2) is indicated, and nominal p-values determined by ANOVA are given when p,0.05.
doi:10.1371/journal.pone.0022462.t001
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PLoS ONE | www.plosone.org 3 July 2011 | Volume 6 | Issue 7 | e22462Figure 1. Cross-specific QTLs in males. (A) QTL for aBMD on chromosome 2 and (B) QTL for ultimate force on chromosome 15. Cross 1 represents
males with GKmtDNA and cross 2 represents males with F344mtDNA.
doi:10.1371/journal.pone.0022462.g001
Table 2. QTLs linked to biomechanics and DXA phenotypes in male and female F2 rats. Suggestive QTLs are reported if
overlapping a significant QTL.
LOD scores
Chr QTL region Position (cM) Phenotype Male (n=108)
Cross 1
(n=66)
Cross 2
(n=42)
Biomechanics 15 D15Rat109-D15Mit2 10–32 Ult force 1.8 3.9
b,c 0.2
DXA 2 D2Mit24-D2Mgh5 45–59 BMC 2.2 0.4 2.8
a
2 D2Mit24-D2Mgh5 45–57 aBMD 2.5
a 0.8 4.7
b,d
6 D6Mgh11-D3Mit19 25–58 BMC 2.5
a 0.8 4.8
b,d
6 D6Mgh11-D3Mit19 30–60 Area 2.8
a 1.3 3.1
a
8 D8Mit3-D8Mit2 35–58 BMC 4.1
b 1.3 2.9
a
8 D8Mit2-D8Mgh4 43–59 Area 4.7
b 1.4 3.3
a
Female (n=98) Cross 1 (n=48)
Cross 2
(n=50)
Biomechanics 1 D1Rat7-D1Mit9 17–40 Ult force 3.6
a 2.5
a 2.5
a
1 D1Rat7-D1Mit9 18–43 Stiffness 5.5
b 4.7
b 3.1
a
15 D15Mit2-Bmyo 25–37 Work to fail 0.5 0.1 2.8
a
DXA 4 D4Mit9-D4Mit24 37–49 aBMD 1.8 3.7
a 0.3
4 D4Mit9-D4Mit24 36–48 BMC 1.7 5.1
b 0.3
X DXRat20-DXRat103 52–74 Area 3.9
b
QTL size defined as the region covered by a 1-LOD reduction for any of the bone traits.
aGenome-wide suggestive QTL (LOD$2.3).
bGenome-wide significant QTL (LOD$3.8).
cSuggestive cross-specific QTLs (DLODcross$2.4) validated by likelihood ratio (LR) tests for QTL-by-cross interaction (p,0.05).
dSignificant cross-specific QTLs (DLODcross$3.9) validated by likelihood ratio (LR) tests for QTL-by-cross interaction (p,0.05).
doi:10.1371/journal.pone.0022462.t002
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in the likelihood ratio test. In males with F344 grand maternal origin
(cross 2), significant linkage was detected on chromosome 2 for
aBMD, and on chromosome 6 for BMC. The QTL on chromosome
2 also overlapped with a suggestive QTL linked to BMC in cross 2
males.ThesignificantQTLsonchromosome2(aBMD)(Fig.1A)and
6 (BMC) reached genome-wide significance in the DLODcross
evaluation (DLODcross$3.9) and cross-specific interactions were
confirmed for both by likelihood ratio tests (LR=10.4, p=0.005
and LR=10.9, p=0.004) respectively.
In females, QTL analysis on the X chromosome without
separation by cross identified a significant QTL linked to tibial
area. The cross-separated QTL analysis revealed significant
linkage to BMC on chromosome 4 (36–48 cM) in females with
GK grand maternal origin (cross 1). An overlapping region also
showed suggestive linkage to aBMD in cross 1. The QTL
identified on chromosome 4 significantly linked to BMC reached
genome-wide significance in the DLODcross evaluation (DLOD-
cross$3.9), but did not reach significance for cross-specific
interaction in the likelihood ratio test. Suggestive QTLs for
DXA phenotypes are reported in table S1.
Co-allelic effects
The GK allele had an increasing effect on genotypic mean
values for the majority of the QTLs significantly linked to both
biomechanical and DXA traits in males and females (Table 3).
There were however also heterosis-like effects, where the
heterozygous group carrying one GK- and one F344 allele
differed significantly from both homozygous groups and had
higher mean aBMD (marker D2Mgh5) and ultimate force (marker
D15Mit2).
Co-localization of QTLs for bone strength-related
phenotypes
By combining the QTLs identified in this study with QTLs
linked to other bone-related phenotypes, overlapping or co-
localized QTLs for biomechanical properties (3PB), bone density
(DXA) and/or bone quality (pQCT and 3D CT) phenotypes were
detected on chromosomes 1, 3, 4, 6, 8 and 10 (Table 4). In order
to increase understanding of the observed genetic co-localizations,
correlation coefficients between phenotypes mapping to the same
region were evaluated. A large region on chromosome 1 (17–
79 cM) displayed linkage to multiple phenotypes obtained from all
four methods (3PB, DXA, pQCT and 3D CT) in both males and
females. The biomechanical phenotypes ultimate force and
stiffness were strongly correlated (0.64–0.88) with the other
phenotypes linked to this region except for cortical volumetric
BMD (cortvBMD) and metaphyseal volumetric BMD (me-
tavBMD;20.02–0.24). Similar patterns were seen at other loci,
where most co-mapped phenotypes were correlated with each
other, with exceptions mainly attributed to biomechanical
phenotypes. For phenotypes linked to chromosome 3 (3–24 cM),
ultimate force strongly correlated with 3D CT and pQCT
phenotypes (0.71–0.88), while correlations with total bone mineral
content (totBMC) and metaphyseal volumetric bone mineral
density (metavBMD) were low (0.04–0.14). The QTLs that co-
localized to chromosome 4 (36–74 cM) were measured by 3PB,
2D DXA and 3D CT and these phenotypes were strongly
correlated (0.63–0.96) with the exception of work to failure which
demonstrated low correlation with the other phenotypes (0.07–
0.26). The same pattern was observed for chromosome 8 (35–
63 cM) with overlapping QTLs from all four methods, but
moderate correlations between work to failure and the other co-
mapped phenotypes. In contrast, strong correlations (0.79–0.91)
were observed for all phenotypes that co-localized to chromosome
6 (25–60 cM) and to chromosome 10 (73–91 cM) (0.45–0.93),
regions where biomechanical phenotypes did not co-map.
Discussion
In this study, we identified multiple QTLs for biomechanical
and two-dimensional DXA phenotypes in F2 progeny of GK and
F344 rats and confirmed bone QTL interactions with reciprocal
cross. Previously, we reported results from a genome-wide screen
for bone size and trabecular and cortical bone structure of tibia in
the same F2 progeny [23,24]. The biomechanical testing reported
here provides bone phenotypes directly reflecting the ability of
bone to resist fracture. We have thus addressed the majority of
clinically important bone properties related to bone strength and
fracture susceptibility.
By combining QTLs linked to distinct bone phenotypes
measured by separate methods, overlapping chromosomal regions
linked to bone size, structure and strength were identified. Two
large regions on chromosomes 1 (17–79 cM) and 8 (35–63 cM)
displayed linkage to multiple phenotypes obtained from four
different methods (3PB, DXA, pQCT and 3D CT) in both males
and females. The regions with overlapping QTLs influenced
different phenotypes, the majority of which were correlated at a
Table 3. Genotypic mean values for biomechanical- and DXA phenotypes with significant linkage to chromosomes 1, 2, 4, 6, 8, 15,
and X.
Chr Peak Marker Phenotype GK/GK GK/F344 F344/F344 (p-value) ANOVA
1 D1Mgh2 Stiffness
F 243.5631.5 199.6634.1 184.2625.8 7.2 E-07
1 D1Mit9 Stiffness
F,Cr1 249.7636.1 199.6630.2 190.3630.9 0.00076
2 D2Mgh5 aBMD
M,Cr2 0.1760.01 0.1860.008 0.1760.007 0.024
4 D4Mit9 BMC
F,Cr1 0.3060.04 0.3260.04 0.3160.04 NS
6 D3Mit19 BMC
M,Cr2 0.4660.05 0.4460.04 0.4060.05 NS
8 D8Mit2 BMC
M 0.4460.04 0.4560.04 0.4360.05 NS
8 D8Mit2 Area
M 2.4560.13 2.5060.16 2.4060.19 NS
15 D15Mit2 Ult force
M,Cr1 110.867.94 126.8614.3 116.3615.6 0.0026
X DXRat20 Area
F 1.8960.10 1.9060.13 1.9460.19 NS
Values are means 6 SD. M=males; F=females; Cr1=Cross 1; Cr2=Cross 2.
doi:10.1371/journal.pone.0022462.t003
Co-Localization of Osteoporosis-Related QTLs
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phenotypes. As an example, overlapping QTLs on chromosome 3
included the biomechanical phenotype ultimate force which was
strongly correlated with the dimensional phenotypes 3D CT- and
pQCT but only weakly correlated with totBMC and metavBMD.
The co-mapping of these phenotypes was thus not due to
phenotype correlation, but represents different aspects of the
QTLs. Co-localization of QTLs for uncorrelated phenotypes
could reflect the existence of distinct sub-loci. Conversely, highly
correlated co-mapped bone phenotypes could reflect pleiotropic
gene effects with dependence between phenotypes. Thus, the
observed co-localizations of QTLs are unlikely to be explained by
phenotypic correlation alone and the regions could each contain
either a single QTL with pleiotropic effects, or several QTLs that
influence the correlated phenotypes independently. Combining
QTLs from different methods allows greater characterization of
the gene regions, indicating whether they are likely to contain one
or several candidate genes and if these are likely to participate in
the same biological processes. Since the biomechanical properties
of bone are the sum of many different characteristics, the lower
correlation of these traits to specific quantitative and qualitative
traits was expected.
The notion that QTLs for bone phenotypes interact specifically
with sex have been reported previously [8] but the observed
interactions between nuclear QTLs for several bone phenotypes
and reciprocal crosses, that differ with regard to mitochondrial
DNA sequence, demonstrates a new and important aspect to be
considered when interpreting the genetics of phenotypes related to
bone strength.
In this study, the reciprocal cross-separated QTL analysis in
males allowed identification of cross-specific interactions for three
QTLs on chromosomes 2 (aBMD), 6 (BMC) and 15 (ultimate
force). The QTLs on chromosomes 2 and 6 were identified in all
males at a suggestive level but showed genome-wide significant
linkage only in the cross with F344 grand maternal origin, while
the QTL on chromosome 15 was only detected in the cross with
GK grand maternal origin and would not have been detected in
the combined sample including both reciprocal crosses. This
illustrates the importance of sub-group analysis and of considering
reciprocal cross effects in order to improve the detection of
candidate genes for fracture susceptibility.
The respective reciprocal cross did not affect the phenotypes at
a population level, as no significant differences were seen between
the phenotypic mean values between cross 1 and cross 2 in either
males or females (Table 1). Instead, the reciprocal effects were seen
as interactions with specific QTLs and thus provide support for
nuclear-mitochondrial interactions to be involved in the genetic
regulation of bone phenotypes. Notwithstanding the mounting
evidence for mitochondrial interactions involved in complex
diseases such as osteoporosis and type-2 diabetes, other factors
such as genomic imprinting, the presence of QTLs on sex
chromosomes and maternal environment, are theoretical expla-
nations for reciprocal cross specific inheritance and may
contribute to the observed effects as previously discussed [23].
Additionally, since all cross-specific QTLs in this study were
identified in males, we cannot exclude the possibility that
interactions with a Y chromosome linked locus could explain the
observed reciprocal cross effect. However, the more than 100
variant positions in both coding and non-coding regions that have
been identified in GK mitochondrial DNA compared to F344
[25,26], support mitochondrial genotype as a possible factor
behind the observed reciprocal cross effect in this study. The
reciprocal cross interactions could thus reflect functional interac-
tion between nuclear- and mitochondrial encoded proteins.
Although the candidate regions are large and contain many
genes, it is interesting to note that the QTL regions on
chromosome 4 and 6 that demonstrated significant reciprocal
cross interaction contain genes encoding mitochondrial proteins.
These include mitochondrial ribosomal protein S33 [Mrps33], the
NADH dehydrogenase (ubiquinone) 1 beta subcomplex 2
[Ndufb2] and glutathione S-transferase kappa 1 [Gstk1] on
chromosome 4 and ATP synthase subunit s [Atp5s] and Acyl-
coenzyme A thiosterase 2 [Acot2] on chromosome 6. In addition,
the region on chromosome 4 overlaps a previously identified QTL
strongly linked to femoral neck structure phenotypes in female
(F3446LEW) F2 rats [14].
Several QTLs identified in this study co-localized with our
previously reported QTLs linked to tibial bone phenotypes obtained
from pQCT and 3D CT [23,24] and were in many cases influenced by
sex- and reciprocal cross (Table 4). The region on chromosome 1 (17–
79 cM) linked to multiple phenotypes obtained from all four methods
(pQCT, 3D CT, 3PB and DXA) in both males and females showed
predominantly higher significance in the reciprocal cross 1 carrying
GK mtDNA. Several QTLs linked to cortical bone traits in other
combinations of rat strains have been mapped to this region [14,16],
emphasizing the importance of this large chromosome region for
variation in bone traits between individuals. The osteoporosis
candidate genes transforming growth beta 1 (TGFB1) [36] and
estrogen receptor alpha (ESR1) [37] are both localized within this
locus. Interestingly, QTLs for fasting glucose also map to this region
[38] making it a strong candidate for focused investigation of possible
shared or linked polymorphisms regulating diabetes- and osteoporosis-
related phenotypes. To clarify shared mechanisms between diabetes
and osteoporosis, such analyses could include congenic strains and/or
advanced intercross lines. It is recognized, as a possible limitations, that
this chromosomal region is large and likely to harbor several sub-loci.
Several established osteoporosis candidate genes are also found
within the human regions syntenic to the chromosome 4 QTL linked
to multiple rat bone strength phenotypes. These include the
calcitonin receptor (7q21.3), collagen 1 alpha 2 (7q21.3) and WNT
2 and WNT 12 from the WNT signalling pathway. The cytokine
macrophage migration inhibitory factor (MIF) gene, recently shown
to be associated with bone loss in elderly women [39] is also located
within this region. The human regions syntenic to the rat
chromosome 6 QTL contains around 140 genes. This region is too
large to pinpoint candidate genes, but interestingly contains genes
which contribute to skeletal development e.g. the transcriptional
regulatorTWIST1 (7p21) and GDF7 (2p24), a member of the TGFB
superfamily. Further delineation of the complex genetic architecture
of bone phenotypes for fracture susceptibility would ideally involve a
genome screen for epistatic interactions between the identified loci.
However, such analysis requires a larger sample size than was
available in this study. Congenic strains or advanced intercross lines
a r ep o s s i b l et o o l sf o rf u t u r ef i n em apping of the identified QTLs, and
would allow for positional cloning of candidate genes and epistatic
interaction analyses, respectively.
In summary, we have identified QTLs for biomechanical and two-
dimensional DXA phenotypes influencing bone strength with
interaction from reciprocal cross in an F2 intercross between GK
and F344 rats. The observed interaction between nuclear QTLs and
reciprocal cross for numerous bone associated phenotypes supports
the potential for mitochondrial effects on bone. By combining data
from this and our previous studies, we were able to identify specific
but also overlapping chromosomal regions for bone size, structure
and strength. These findings illustrate the importance of analysing
differentdeterminantscontributing tobone strength inorder todetect
candidate genes or pathways for bone regulation, from the macro- to
the micro-structural level. Of particular interest is the identified QTL
Co-Localization of Osteoporosis-Related QTLs
PLoS ONE | www.plosone.org 7 July 2011 | Volume 6 | Issue 7 | e22462region on chromosome 1 linked to many bone phenotypes and also
r e p o r t e dt oa f f e c tf a s t i n gg l u c o s e .T h i sr e g i o ni st h u sas t r o n g
candidate for the identification of genes contributing to bone
regulation and potentially type-2 diabetes.
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